BDBM362369 4-{7-amino-3-[(3R)-1- (1,2,5-oxadiazol-3- ylcarbonyl)piperidin-3- yl]-1H-pyrazolo[3,4-c]pyridin-1-yl}- N-[4-(trifluoromethyl)pyridin- 2-yl]benzamide::US9834554, Example 13

SMILES Nc1nccc2c(nn(-c3ccc(cc3)C(=O)Nc3cc(ccn3)C(F)(F)F)c12)[C@@H]1CCCN(C1)C(=O)c1cnon1

InChI Key InChIKey=ZNOAFBDRDLBAKT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 362369   

TargetTyrosine-protein kinase BTK(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM362369(US9834554, Example 13 | 4-{7-amino-3-[(3R)-1- (1,2...)
Affinity DataIC50: 4.70nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2019
Entry Details
Go to US Patent